Traduction de «testing for blood » (Néerlandais → Français) :

TERMINOLOGIE

wiegendood, dysgenesie van testes
syndrome de mort subite du nourrisson-dysgénésie des testicules

vergroeiing van testes
Fusion des testicules

serologische test, vals-positief, voor syfilis
Résultats faussement positifs au test sérologique de la syphilis

open wond van scrotum en testes
Plaie ouverte du scrotum et des testicules

serologische test
test sérologique

pap-test, abnormaal
frottis de Papanicolaou anormal

test hepatitis A immuun
immunisé contre l'hépatite A

test hepatitis B immuun
immunisé contre l'hépatite B

moleculaire genetische test
test génétique moléculaire

onderzoek en tests verband houdend met voortplanting
Recherches et tests en vue d'une procréation

TRADUCTIONS EN CONTEXTE

Deze bijkomende NAT-testing kon de diagnostische window periode voor HCV reduceren van 41-60 dagen tot 15- 22 dagen (Busch et al., 2000; Zou et al., 2010). Analoge reductie van de diagnostische window periode werd ook gezien voor HIV. Onderzoek door de interorganisational Task force on NAT-testing of blood donors in de Verenigde Staten toonde een reductie van de windowfase met 10 – 15 dagen tot ongeveer 10 dagen (Paul-Ehrlich, 2003).
Celui-ci a permis de réduire la fenêtre sérologique pour le diagnostic du HCV de 41-60 jours à 15-22 jours (Busch et al., 2000; Zou et al., 2010).

Het ‘NIH Consensus Panel on Infectious Disease Testing for Blood Transfusions’ besloot in 1995 tot een gelijkaardige aanbeveling, namelijk dat ALT testen van vrijwillige bloeddonoren niet langer wetenschappelijk verantwoord was en daarom niet meer hoefde te gebeuren.
Le ‘NIH Consensus Panel on Infectious Disease Testing for Blood Transfusions’ s’est rallié en 1995 à une recommandation similaire, à savoir que les tests ALT des donneurs de sang volontaires n’était plus justifiée d’un point de vue scientifique et ne devait dès lors plus être effectuée.

- Schmidt MS, Hourfar MKH, Schellenberg ES, et al. One year experience after implementation of anti-HBc testing into blood donor screening in Germany.
- Schmidt M, Hourfar MKH, Schellenberg ES, et al. One year experience after implementation of anti-HBc testing into blood donor screening in Germany.

Nucleic acid sequence based amplification Nucleic Acid Amplification Testing Non-heart beating donors National Institute for Biological Standards and Control Optische densiteit Occupational Safety and Health Administration Perazijnzuur Phosphate buffered saline Polymerase chain reaction Perazijnzuur ethanol sterilisatie Positive predictive value Positief predictieve waarde Polyvinyl-pyrrolidon Povidone-iodine Quaternaire ammoniumverbindingen Radio-immunoprecipitatie test Ribonucleic acid Ribonuclease H Respiratoir syncytiaal virus Reverse transcriptase Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Median tissue culture infective dose Transcription-mediated amplification Tumor necrosis factor United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Verenigde Staten Werkgroep infectiepreventie West Nile virus World Health Organization
Morbidity and mortalility weekly report Nucleic acid sequence based amplification Nucleic Acid Amplification Testing National Institute for Biological Standards and Control Occupational Safety and Health Administration Phosphate buffered saline ou tampon phosphate Polymerase chain reaction Stérilisation acide peracétique-éthanol Positive predictive value Polyvinyl-pyrrolidon Povidone-iodine Dérivés de l’ammonium quaternaire Ribonuclease H Reverse transcriptase ou transcriptase inverse Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Syndrome d’immunodéficience acquise Median tissue culture infective dose Test d’immunofluorescence indirecte Transcription-mediated amplification Tumor necrosis factor Test de radio-immunoprécipitation United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Valeur prédictive positive Virus respiratoire syncytial Etats-Unis Werkgroep infectiepreventie ou groupe de travail sur la prévention des infections West Nile virus World Health Organization

serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about
serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about

Urine analysis 47% Hb : history of anemia or history suggesting recent blood loss or anemia K : if digoxin or diuretics Haemostasis : history of coagulation abnormalities or recent history suggesting coagulations problems or on anticoagulants The routine test of Hb leads to a change of management in 0.1% to 2.7% of patients.
Full blood count 95% Haemostasis 98% Renal function 99% Random glucose Not included Blood gases Not included Pregnancy test 78% Urine analysis 47% Hb : history of anemia or history suggesting recent blood loss or anemia K : if digoxin or diuretics Haemostasis : history of coagulation abnormalities or recent history suggesting coagulations problems or on anticoagulants The routine test of Hb leads to a change of management in 0.1% to 2.7% of patients.

Another significant expenditure item is payment of the subsidy for financing NAT blood tests, which came to 9,751,000 euros or 22% of expenses.
Another significant expenditure item is payment of the subsidy for financing NAT blood tests, which came to 9,751,000 euros or 22% of expenses.

disease and blood screening tests» Current Opinion in Hematology, Vol. 11:351-356, 2004. l) Uiteenzetting « Modelling of effects of the exclusion of transfusion recipients» TSE -
disease and blood screening tests» Current Opinion in Hematology, Vol. 11:351-356, 2004. l) Exposé « Modelling of effects of the exclusion of transfusion recipients» TSE - Safety

- Schmidt MS, Nübling CM, Scheiblauer H, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
- Schmidt M, Nübling CM, Scheiblauer H, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.

Immunochemical Faecal Occult Blood Tests for Colorectal Cancer Screening (mei 2013) (HGR 8901) (voorlopig enkel in het Engels beschikbaar)
Immunochemical Faecal Occult Blood Tests for Colorectal Cancer Screening (mai 2013) (CSS 8901)